ArticleJSES international2026
Outcomes at mean 8-year follow-up after reverse total shoulder arthroplasty for failed fracture treatment.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Proximal humerus fractures are a common challenge in patients with initial treatment ranging from nonoperative management, to open reduction and internal fixation, to arthroplasty. Initial treatment failure is not uncommon, and revision to reverse total shoulder arthroplasty (rTSA) has emerged as a viable salvage option, though long-term outcomes in these patients are variable and remain underreported. This study aimed to evaluate long-term outcomes and failure rates of rTSA after failed initial proximal humerus management (nonoperative and operative). We hypothesized that rTSA for sequelae of fracture after failed treatment would lead to durable and beneficial outcome as well as a low failure rate. Methods: After institutional review board approval, a retrospective review was conducted of patients who underwent rTSA for sequelae of fracture for failed treatment between 2007 and 2020, with a minimum of 24 months' follow-up. Outcomes included American Shoulder and Elbow Surgeons (ASES), Quick Disabilities of the Arm, Shoulder, and Hand, Single Assessment Numeric Evaluation, 12-Item Short-Form Health Survey (Physical Component Summary/Mental Component Summary), pain scores, range of motion and complication/failure rates. Statistical analyses were performed using paired tests, with significance set at Results: Sixteen shoulders (84.2%) of 15 patients were included in the final analysis. The mean follow-up was 100.8 ± 48.1 months. Significant improvements were observed in ASES (from 45.8 to 69.6; Conclusion: rTSA performed for sequelae of fracture to failed initial treatment (nonoperative or operative) of proximal humerus fractures was associated with substantial and durable improvement in pain and patient-reported function as well as restoration of range of motion, with a low rate of subsequent construct revision in this cohort. These findings support rTSA for sequelae of fracture as a suitable treatment option when initial management fails in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.